Geert R D'Haens

33PUBLICATIONS
142CO-AUTHORS
Pharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Apr 24, 2026
Efficacy and safety of ABBV-154 in patients with moderately to severely active Crohn's disease: a phase 2b, randomized, double-blind, placebo-controlled trial.

|Nov 28, 2025
One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy Participants.

Yuki Otani, Christopher D Payne, Edward V Loftus

|Nov 21, 2025
Mucosal B Cell Expansion and Maturation Contribute to Colitis Pathogenesis.

Ivan C N Fung, Pim J Koelink, Lieven G M Mulders

|May 07, 2025
Clinical Utility and Accuracy of Point-of-Care Testing for Anti-TNF Drug Monitoring and Loss of Response.

Christoph Teichert, Suzanne I Anjie, Toer W Stevens

|Mar 21, 2025
Pharmacokinetic Comparability and Safety Between Original and Citrate-Free Mirikizumab Formulations for Subcutaneous Injections: Results from Three Clinical Trials.

Yuki Otani, Brian G Feagan, Geert R D'Haens

|Feb 11, 2025
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference.

Loris R Lopetuso, Sara Deleu, Pierluigi Puca

Pageof 6

Frequent Collaborators

7 joint publications

Séverine Vermeire

7 joint publications

Remo Panaccione

5 joint publications

Silvio Danese

4 joint publications

Brian G Feagan